2019-2020 Session
Change SessionS.296
An act relating to limiting out-of-pocket expenses for prescription insulin drugs
- Sponsor(s)
- Location
- House Committee on Health Care
- Last Recorded Action
- House 3/13/2020 - Referred to the Committee on Health Care
Bill/Resolution Text
NOTE: to print information that appears on a tab within the bill page, use the Print link on that tab.
An act relating to limiting out-of-pocket expenses for prescription insulin drugs
Detailed Status
Regular Session 2019-2020
Body | Date | Journal | Calendar | Location | Full Status |
---|
An act relating to limiting out-of-pocket expenses for prescription insulin drugs
Roll Call History
Regular Session 2019-2020
Body | Date | Journal | Location | Full Status |
---|
Although procedurally bills and resolutions are assigned to only one committee at a time, other committees may review the bill or resolution. This page contains results from both the assigned committee as well as other committees.
An act relating to limiting out-of-pocket expenses for prescription insulin drugs
Committee Meetings
Regular Session 2019-2020
Meeting Date | Committee |
---|
An act relating to limiting out-of-pocket expenses for prescription insulin drugs
Meeting Full List
Regular Session 2019-2020
Friday, January 24, 2020
- Committee(s):
- Senate Committee on Finance
- 3:00 PM
-
S.296 - An act relating to limiting out-of-pocket expenses for prescription insulin drugs
Walk-through
Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel
Stephen Habbe, Director State Government Affairs, American Diabetes Association
Kevin O'Hara, Williston, Vermont
Thursday, February 6, 2020
- Committee(s):
- Senate Committee on Finance
- 3:40 PM
-
S.296 - An act relating to limiting out-of-pocket expenses for prescription insulin drugs
Margaret Laggis, Lobbyist, America's Health Insurance Plans
Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
Michael Fisher, Chief Health Care Advocate, Office of the Health Care Advocate, Vermont Legal Aid
Tuesday, February 11, 2020
- Committee(s):
- Senate Committee on Finance
- 4:10 PM
-
S.296 - An act relating to limiting out-of-pocket expenses for prescription insulin drugs
Testimony
Saumya Saini, Vermont Medical Society
Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Wednesday, February 12, 2020
- Committee(s):
- Senate Committee on Finance
- 3:30 PM
-
S.296 - An act relating to limiting out-of-pocket expenses for prescription insulin drugs
Pharmacy Benefits, 340b Pricing, Mark-up and Possible Vote
Nancy Hogue, Director of Pharmacy Services, Department of Vermont Health Access (DVHA)
Brian Murphy, Director of Pharmacy and Vendor Management, Blue Cross Blue Shield of Vermont
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
Michael Fisher, Chief Health Care Advocate, Office of the Health Care Advocate, Vermont Legal Aid
Friday, February 21, 2020
- Committee(s):
- Senate Committee on Finance
- 1:30 PM
-
S.296 - An act relating to limiting out-of-pocket expenses for prescription insulin drugs
Committee Discussion, Mark-up and Possible Vote
Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Tuesday, February 25, 2020
- Committee(s):
- Senate Committee on Finance
- 4:45 PM
-
S.296 - An act relating to limiting out-of-pocket expenses for prescription insulin drugs
Testimony, Review Draft and Vote
Elia Spates Marquis, Newport
Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel
Tuesday, March 10, 2020
- Committee(s):
- Senate Committee on Finance
- 4:35 PM
-
S.296 - An act relating to limiting out-of-pocket expenses for prescription insulin drugs
Sirotkin Amendment
Committee Documents
An act relating to limiting out-of-pocket expenses for prescription insulin drugs
Witnesses Who Testified
Regular Session 2019-2020
Senate Committee on Finance
- Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel
- Michael Fisher, Chief Health Care Advocate, Office of the Health Care Advocate, Vermont Legal Aid
- Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
- Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
- Stephen Habbe, Director State Government Affairs, American Diabetes Association
- Nancy Hogue, Director of Pharmacy Services, Department of Vermont Health Access (DVHA)
- Margaret Laggis, Lobbyist, America's Health Insurance Plans
- Elia Spates Marquis, Newport
- Brian Murphy, Director of Pharmacy and Vendor Management, Blue Cross Blue Shield of Vermont
- Kevin O'Hara, Williston, Vermont
- Saumya Saini, Vermont Medical Society
- Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
Fiscal notes and materials available on this web page are provided for informational purposes only, and may not comprise all materials received by the Vermont Legislature or the final fiscal information related to a specific bill. The Legislature is not responsible for the accuracy of any information in these materials, and their posting does not constitute approval or endorsement by the Legislature.
No fiscal documents found for S.296 in the Regular Session 2019-2020.
No committee of conference members found for S.296 in the Regular Session 2019-2020.
An act relating to limiting out-of-pocket expenses for prescription insulin drugs
Committee of Conference Meetings
Regular Session 2019-2020
Meeting Date | Committee |
---|